-
Mashup Score: 15Cryoglobulinemia — One Name for Two Diseases | NEJM - 2 hour(s) ago
Cryoglobulinemia is caused by the precipitation of immunoglobulin molecules when plasma or blood cools to 4°C. The term is routinely applied to two distinct disease entities that need to be disting…
Source: www.nejm.orgCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 0December 12, 2024 | NEJM - 7 hour(s) ago
Image Challenge from the New England Journal of Medicine — December 12, 2024
Source: www.nejm.orgCategories: General Medicine News, PulmonologyTweet-
What is the most likely diagnosis? https://t.co/hN4j0yXmmj 4/4
-
-
Mashup Score: 0A Diagnostic Sequence | NEJM - 9 hour(s) ago
This video explores the differential diagnosis for acute-on-chronic pulmonary disease and highlights the importance of keeping a broad differential throughout a patient’s course of illness.
Source: www.nejm.orgCategories: General Medicine News, Allergy-ImmunologyTweet-
A Diagnostic Sequence: this Double Take video from the New England Journal of Medicine presents the case of a 42-year-old woman presenting with cough, fatigue, fevers, and shortness of breath. https://t.co/mtHAeKSRTF https://t.co/DI9xF4SwoQ
-
-
Mashup Score: 2Pleural Plaques from Secondhand Asbestos Exposure | NEJM - 10 hour(s) ago
An 80-year-old woman had pleural plaques seen on chest radiographs. As a child, she had played with her father after he returned home from work with his clothing covered in “snow-like” particles.
Source: www.nejm.orgCategories: General Medicine News, General HCPsTweet-
Images in Clinical Medicine meets the short story. Pleural Plaques from Secondhand Asbestos Exposure | New England Journal of Medicine https://t.co/laVWvvhe0W
-
-
Mashup Score: 12
Imlunestrant is a next-generation, brain-penetrant, oral selective estrogen-receptor (ER) degrader that delivers continuous ER inhibition, even in cancers with mutations in the gene encoding ERα (E…
Source: www.nejm.orgCategories: General Medicine News, General HCPsTweet-
EMBER-3: The selective estrogen-receptor degrader imlunestrant plus abemaciclib led to a median progression-free survival of 9.4 months among patients with ER-positive, HER2-negative breast cancer (vs. 5.5 months with imlunestrant alone). https://t.co/6b4XE6fyX9 #SABCS24 https://t.co/zoHxKU54Sm
-
-
Mashup Score: 0Tethered | NEJM - 12 hour(s) ago
When a bright young adult patient who had been planning his future moves back home to help his sick mother, his own emerging health problems are hard to interpret — until it’s too late.
Source: www.nejm.orgCategories: General Medicine News, Critical CareTweet-
When a bright young adult patient who had been planning his future moves back home to help his sick mother, his own emerging health problems are hard to interpret — until it’s too late. Read the Perspective by Mark Earnest, MD, PhD: https://t.co/8UMdYtHZws https://t.co/hvz4GYxnNi
-
-
Mashup Score: 11
Whether surgical axillary staging as part of breast-conserving therapy can be omitted without compromising survival has remained unclear. In this prospective, randomized, noninferiority trial, we i…
Source: www.nejm.orgCategories: General Medicine News, General Journals & SocietTweet-
Presented at #SABCS24: The INSEMA randomized trial involving patients with clinically node-negative, T1 breast cancer showed that the omission of axillary surgery was noninferior to sentinel-lymph-node biopsy. Full trial results: https://t.co/u1exDbl8XK https://t.co/FeBW6ag2gd
-
-
Mashup Score: 10
A December 2022 law introduced a new expedited withdrawal process for accelerated approvals. The first approval withdrawn with this pathway was that of melphalan flufenamide.
Source: www.nejm.orgCategories: General Medicine News, General HCPsTweet-
Two New Perspectives: 1️⃣ Autopsy of a Drug Withdrawal https://t.co/cNwSTXnMVH 2️⃣ Tethered https://t.co/8UMdYtHZws Subscribe to NEJM for the latest medical research: https://t.co/ubSljYgIVg
-
-
Mashup Score: 0Interview with Bindu Kanapuru on the FDA’s new expedited withdrawal procedure for accelerated approvals. | NEJM - 14 hour(s) ago
Audio Interview from the New England Journal of Medicine — Interview with Bindu Kanapuru on the FDA’s new expedited withdrawal procedure for accelerated approvals.
Source: www.nejm.orgCategories: General Medicine News, Oncologists1Tweet-
Interview with FDA hematologist-oncologist Bindu Kanapuru on the FDA’s new expedited withdrawal procedure for accelerated approvals - via @NEJM https://t.co/sMuepv05po
-
-
Mashup Score: 9
The role of axillary surgery in the management of breast cancer has changed. Sentinel-lymph-node biopsy is used to identify nodal metastases, but recognition of the lack of therapeutic benefit of t…
Source: www.nejm.orgCategories: General Medicine News, General Journals & SocietTweet-
Editorial: Sentinel-Lymph-Node Biopsy in Early-Stage Breast Cancer — Is It Obsolete? https://t.co/eHsZBFtO4E
-
Cryoglobulinemia is caused by the precipitation of immunoglobulin molecules when plasma or blood cools to 4°C. The term is routinely applied to two distinct disease entities that need to be distinguished from one another. Read the full review: https://t.co/tP7GUi0zKY https://t.co/mtoYzWzEMU